IMP3 protein is an independent prognostic factor of clinical stage II rectal cancer
نویسندگان
چکیده
منابع مشابه
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.
BACKGROUND Molecular markers in colon cancer are needed for a more accurate classification and personalized treatment. We determined the effects on clinical outcome of the BRAF mutation, microsatellite instability (MSI) and KRAS mutations in stage II and stage III colon carcinoma. PATIENTS AND METHODS Stage II colon carcinoma patients (n = 106) treated with surgery only and 258 stage III pati...
متن کاملNuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients
Emerging evidence has implicated a pivotal role for lysyl oxidase (LOX) in cancer progression and metastasis. Whilst the majority of work has focused on the extracellular matrix cross-linking role of LOX, the exact function of intracellular LOX localisation remains unclear. In this study, we analysed the LOX expression patterns in the nuclei of rectal cancer patient samples and determined the c...
متن کاملHypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patients.
PURPOSE Hypoxia is considered a major microenvironmental factor influencing cancer behavior. Our aim was to develop a hypoxia-based gene score that could identify high and low risk within stage II and III colon cancer patients. EXPERIMENTAL DESIGN Differential gene expression of CaCo-2 colon cancer cells cultured in chronic hypoxia versus normoxia was tested for correlation with prognostic va...
متن کاملLeft laterality is an independent prognostic factor for metastasis in N3 stage breast cancer.
PURPOSE Development of metastasis in patients with breast cancer (BC) is the most important negative prognostic factor and this process mainly begins with lymphatic involvement. Therefore, axillary, subclavicular, internal mammary or supraclavicular nodal involvement is a crucial step before metastasis. Anatomical differences between the right and left lymphatic drainages of the breasts may sig...
متن کاملCD73 Expression Is an Independent Prognostic Factor in Prostate Cancer.
PURPOSE CD73 is an adenosine-generating ecto-enzyme that suppresses antitumor immunity in mouse models of cancer, including prostate cancer. Although high levels of CD73 are associated with poor prognosis in various types of cancer, the clinical impact of CD73 in prostate cancer remains unclear. EXPERIMENTAL DESIGN We evaluated the prognostic value of CD73 protein expression and CD8(+) cell d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scientific Reports
سال: 2021
ISSN: 2045-2322
DOI: 10.1038/s41598-021-90513-y